Company Tilray, Inc. Nasdaq

APHA

CA03765K1049

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.

Number of employees: 1,600

Managers	Title	Age	Since
Irwin Simon CEO	Chief Executive Officer	65	30/21/30
Carl Merton DFI	Director of Finance/CFO	-	30/21/30
Lloyd Brathwaite CTO	Chief Tech/Sci/R&D Officer	-	30/21/30
Roger Savell ADM	Chief Administrative Officer	-	01/22/01
Berrin Noorata IRO	Public Communications Contact	-	30/21/30
Nyree Pinto HRO	Human Resources Officer	-	01/19/01
Jonathan Simone		-	-
Natalie Bucceri PRN	Corporate Officer/Principal	-	-
Blair MacNeil PRN	Corporate Officer/Principal	-	-
Jared Simon PRN	Corporate Officer/Principal	-	30/21/30

Members of the board	Title	Age	Since
Irwin Simon CEO	Chief Executive Officer	65	30/21/30
David Clanachan BRD	Director/Board Member	62	30/21/30
Walter Robb BRD	Director/Board Member	70	30/21/30
Renah Persofsky BRD	Director/Board Member	65	30/21/30
David Hopkinson BRD	Director/Board Member	53	30/21/30
Thomas Looney BRD	Director/Board Member	61	30/21/30
Jodi Butts BRD	Director/Board Member	51	30/21/30
John Herhalt BRD	Director/Board Member	67	30/21/30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	825,841,998	815,580,237 ( 98.76 %)	0	98.76 %

Name	Equities	%	Valuation
Tidal Investments LLC 1.379 %	10,677,428	1.379 %	541 M $
ETF Managers Group LLC 1.136 %	8,792,652	1.136 %	445 M $
Susquehanna Investment Group LLC 1.017 %	7,872,581	1.017 %	399 M $
Jane Street Group LLC 0.6155 %	4,763,835	0.6155 %	241 M $
Two Sigma Investments LP 0.5759 %	4,457,548	0.5759 %	226 M $
Vanguard Investments Australia Ltd. 0.4554 %	3,525,160	0.4554 %	179 M $
Goldman Sachs & Co. LLC 0.4126 %	3,193,505	0.4126 %	162 M $
Irwin Simon 0.3730 %	2,886,915	0.3730 %	146 M $
Global X Management Co. LLC 0.3462 %	2,679,532	0.3462 %	136 M $
Morgan Stanley Investment Management, Inc. 0.3427 %	2,652,489	0.3427 %	134 M $

Tilray Brands, Inc.

265 Talbot Street West

N8H 5L4, Leamington

+844-845-7291

http://www.tilray.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+45.82%	765B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.77%	248B
ROCHE HOLDING AG	-2.00%	219B
NOVARTIS AG	+10.88%	216B
AMGEN INC.	+5.90%	164B
PFIZER, INC.	-0.73%	162B